Second...spend some money to have the market value of the drug estimated ...discuss that value and how the company sees it being realized in the future....ie, looking at partnerships, etc..whats the go to market strategy here? Need more certainty in all of this for investors to take note.
In the interview posted yesterday, He alluded to mice trials starting in December, and when asked about monetization and time lines hey skirted the question entirely.